(NYSE: STDN) Standard Nuclear's forecast annual revenue growth rate of N/A is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.94%.
Standard Nuclear's revenue in 2026 is N/A.On average, 8 Wall Street analysts forecast STDN's revenue for 2026 to be $2,645,551,209, with the lowest STDN revenue forecast at $2,301,296,099, and the highest STDN revenue forecast at $2,871,453,948. On average, 8 Wall Street analysts forecast STDN's revenue for 2027 to be $9,643,839,610, with the lowest STDN revenue forecast at $8,054,536,345, and the highest STDN revenue forecast at $10,339,394,614.
In 2028, STDN is forecast to generate $53,374,414,410 in revenue, with the lowest revenue forecast at $25,467,676,823 and the highest revenue forecast at $63,943,155,880.